Difference between revisions of "ZSCAN2-DT"

From LncRNAWiki
Jump to: navigation, search
(Created page with "''ZKSCAN2-DT'', ==Annotated Information== ===Approved Symbol=== ''ZKSCAN2-DT'' ===Approved Name=== ''ZKSCAN2-DT'': ===Characteristics=== ''ZKSCAN2-DT'' is a long noncoding...")
 
(Approved Name)
Line 4: Line 4:
 
''ZKSCAN2-DT''
 
''ZKSCAN2-DT''
 
===Approved Name===
 
===Approved Name===
''ZKSCAN2-DT'':  
+
''ZKSCAN2-DT'': ZKSCAN2 divergent transcript,
 
+
CTD-2547G23.4
  
 
===Characteristics===
 
===Characteristics===

Revision as of 03:09, 26 December 2018

ZKSCAN2-DT,

Annotated Information

Approved Symbol

ZKSCAN2-DT

Approved Name

ZKSCAN2-DT: ZKSCAN2 divergent transcript, CTD-2547G23.4

Characteristics

ZKSCAN2-DT is a long noncoding RNA with ensemble id ENSG00000274925. There is 1 noncoding exon and a Transcript length of 3115 bp [1].

Function

ZKSCAN2-DT play a key role in the progress of HCC through four hub genes, SRC, CREBBP, ADCY8 and PPARA [1].

Regulation

NA

Diseases

  • Hepatocellular carcinoma [1].

Expression

ZKSCAN2-DT was significantly up-regulated in HCC samples. It is found that increased ZKSCAN2-DT expression was associated with the neoplasm histologic grade and vascular tumour cell type [1].

Labs working on this lncRNA

  • Department of Medical Ultrasonics, First Affiliated Hospital of Guangxi Medical University, Nanning, 530021 Guangxi Zhuang Autonomous Region People’s Republic of China
  • Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, 530021 Guangxi Zhuang Autonomous Region People’s Republic of China

References

  1. 1.0 1.1 1.2 1.3 Wen DY, Lin P, Liang HW, Yang X, Lil HY, He Y et al. Up-regulation of CTD-2547G23.4 in hepatocellular carcinoma tissues and its prospective molecular regulatory mechanism: a novel qRT-PCR and bioinformatics analysis study[J]. Cancer Cell Int. 2018

Sequence

Please input sequence here.